Overview
The goal of this clinical trial is to learn if a new medical device called ResQ works to predict fluid needs in adults undergoing surgery under general anesthesia. The main questions it aims to answer are:
- Can the Acoustic Variability Index (AVI) measured by ResQ predict if a participant needs more fluids as accurately as the standard arterial blood pressure-based method (PPV)?
- Is the ResQ device safe to use during surgery? Researchers will compare the new method (AVI) to the standard method (PPV) to see if ResQ provides reliable information for managing patient fluids.
Participants will:
- Undergo their planned surgery as scheduled.
- Have a soft probe placed in the esophagus to monitor heart and lung sounds.
- Receive a set amount of intravenous (IV) fluid as part of their regular surgery care.
- Have their heart function checked before and after the fluids are given.
Eligibility
Inclusion Criteria:
- Patients \> 18 years
- Histological and cytological diagnosis of colorectal cancer neoplasia that has developed a liver metastasis
- Patients who are candidates for surgery for colorectal cancer with liver metastasis
- Signing of the relevant informed consent form.
Exclusion Criteria:
- All exclusion criteria adopted in surgical protocols will be applied to the study
